• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腮腺涎腺导管癌中的骨髓转移

Bone marrow metastases in salivary duct carcinoma of the parotid gland.

作者信息

Asarkar Ameya, Takalkar Amol, Dhawan Manish, Nathan Cherie Ann O

机构信息

Department of Otolaryngology/HNS, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.

Center for Molecular Imaging and Therapy, Biomedical Research Foundation of Northwest Louisiana, Shreveport, Louisiana, USA.

出版信息

BMJ Case Rep. 2018 Dec 3;11(1):bcr2018226636. doi: 10.1136/bcr-2018-226636.

DOI:10.1136/bcr-2018-226636
PMID:30567167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6301760/
Abstract

Salivary duct carcinoma (SDC) is a rare and extremely aggressive salivary gland cancer. An 81-year-old woman with SDC underwent a total parotidectomy with facial nerve sacrifice and a neck dissection. Following surgery, she was diagnosed with disseminated bone marrow metastases. She underwent chemotherapy and trastuzumab for palliation. We present a case of SDC of the parotid which was diagnosed with disseminated bone marrow metastasis following surgery for the primary. This case also highlights the importance of having a high index of suspicion while evaluating highly aggressive tumours like SDC for any atypical findings during workup.

摘要

涎腺导管癌(SDC)是一种罕见且侵袭性极强的涎腺癌。一名81岁患有涎腺导管癌的女性接受了牺牲面神经的全腮腺切除术及颈部淋巴结清扫术。术后,她被诊断为骨髓弥漫性转移。她接受了化疗和曲妥珠单抗治疗以缓解症状。我们报告一例腮腺涎腺导管癌病例,该病例在原发性肿瘤手术后被诊断为骨髓弥漫性转移。该病例还凸显了在评估像涎腺导管癌这样的高度侵袭性肿瘤时,在检查过程中对任何非典型发现保持高度怀疑的重要性。

相似文献

1
Bone marrow metastases in salivary duct carcinoma of the parotid gland.腮腺涎腺导管癌中的骨髓转移
BMJ Case Rep. 2018 Dec 3;11(1):bcr2018226636. doi: 10.1136/bcr-2018-226636.
2
Salivary duct carcinoma: clinical characteristics and treatment strategies.涎腺导管癌:临床特征与治疗策略
Head Neck. 1997 Mar;19(2):126-33. doi: 10.1002/(sici)1097-0347(199703)19:2<126::aid-hed7>3.0.co;2-6.
3
Parotid salivary duct carcinoma: a single institution's 20-year experience.腮腺涎腺癌:一家机构的20年经验
Eur Arch Otorhinolaryngol. 2019 Jul;276(7):2031-2038. doi: 10.1007/s00405-019-05454-0. Epub 2019 May 6.
4
Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland.腮腺罕见涎腺导管癌的临床病理特征及治疗结果
J Otolaryngol Head Neck Surg. 2016 May 16;45(1):32. doi: 10.1186/s40463-016-0146-2.
5
Salivary duct carcinoma responding to trastuzumab-based therapy: case report and review of the literature.曲妥珠单抗为基础的治疗有效唾液腺癌:病例报告及文献复习。
Head Neck. 2013 Dec;35(12):E372-5. doi: 10.1002/hed.23307. Epub 2013 Jun 14.
6
[Salivary ductal carcinoma of the parotid: A rare and agressive entity].[腮腺涎腺导管癌:一种罕见且侵袭性的实体瘤]
Cancer Radiother. 2020 Apr;24(2):135-137. doi: 10.1016/j.canrad.2019.06.016. Epub 2020 Jan 25.
7
Metastatic Salivary Ductal Carcinoma to the Mastoid Segment of the Facial Nerve.转移性涎腺癌至面神经乳突段。
Otol Neurotol. 2018 Sep;39(8):e722-e725. doi: 10.1097/MAO.0000000000001923.
8
Salivary Duct Carcinoma of the Parotid Gland Originating from an Epithelial-Myoepithelial Carcinoma: Report of a Rare Case.起源于上皮-肌上皮癌的腮腺涎腺导管癌:1例罕见病例报告。
Head Neck Pathol. 2020 Mar;14(1):283-289. doi: 10.1007/s12105-019-01034-0. Epub 2019 Apr 1.
9
[Distant metastases on acinic cell carcinoma of the parotid gland after 12 years symptom-free interval].[腮腺腺泡细胞癌在无症状间隔12年后出现远处转移]
Laryngorhinootologie. 2006 Aug;85(8):586-8. doi: 10.1055/s-2005-921088.
10
Salivary duct carcinoma of the parotid gland: clinical and MR features in six patients.腮腺涎腺导管癌:6例患者的临床及磁共振成像特征
Br J Radiol. 2009 Oct;82(982):800-4. doi: 10.1259/bjr/29600237. Epub 2009 Mar 30.

本文引用的文献

1
Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland.腮腺罕见涎腺导管癌的临床病理特征及治疗结果
J Otolaryngol Head Neck Surg. 2016 May 16;45(1):32. doi: 10.1186/s40463-016-0146-2.
2
A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.75例涎腺导管癌的20年回顾
JAMA Otolaryngol Head Neck Surg. 2016 May 1;142(5):489-95. doi: 10.1001/jamaoto.2015.3930.
3
Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients.涎腺导管癌的临床结局和预后因素:141例患者的多机构分析
Ann Surg Oncol. 2016 Jun;23(6):2038-45. doi: 10.1245/s10434-015-5082-2. Epub 2016 Jan 20.
4
Salivary duct carcinoma: Treatment, outcomes, and patterns of failure.涎腺导管癌:治疗、预后及失败模式。
Head Neck. 2016 Apr;38 Suppl 1:E820-6. doi: 10.1002/hed.24107. Epub 2015 Jul 15.
5
Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database.浸润性涎腺导管癌的生存率及预后因素:来自监测、流行病学和最终结果数据库的228例病例分析。
Head Neck. 2014 May;36(5):694-701. doi: 10.1002/hed.23350. Epub 2013 Oct 7.
6
Trastuzumab for the treatment of salivary duct carcinoma.曲妥珠单抗治疗唾液腺癌。
Oncologist. 2013;18(3):294-300. doi: 10.1634/theoncologist.2012-0369. Epub 2013 Feb 21.
7
Salivary duct carcinoma of the parotid gland.腮腺涎腺导管癌
J Oral Maxillofac Pathol. 2012 Jan;16(1):134-6. doi: 10.4103/0973-029X.92992.
8
Salivary duct carcinoma of parotid gland.腮腺涎腺导管癌
J Oral Maxillofac Pathol. 2009 Jul;13(2):85-8. doi: 10.4103/0973-029X.57676.
9
Salivary duct carcinoma of the parotid.腮腺涎腺癌。
Eur Ann Otorhinolaryngol Head Neck Dis. 2011 Sep;128(4):194-6. doi: 10.1016/j.anorl.2010.12.008. Epub 2011 Apr 6.
10
Update on selected salivary gland neoplasms.特定涎腺肿瘤的最新进展
Arch Pathol Lab Med. 2009 Nov;133(11):1763-74. doi: 10.5858/133.11.1763.